Skip to main content

Advertisement

SpringerLink
Log in

Targeting RAF-MEK-ERK kinase-scaffold interactions in cancer

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

The RAS-RAF-MEK-ERK signaling kinase pathway has been the focus of intense cancer drug development efforts because of its central role in tumor cell proliferation and survival. Although inhibitors of RAF and MEK provide therapeutic validation, tumor resistance challenges their effectiveness. Targeting scaffolding proteins such as IQGAP1 may be a new approach (pages 626–630).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: The level of IQGAP1 expression is crucial for maintaining oncogenic phospho-ERK signaling.

Katie Vicari

References

  1. Flaherty, K.T. et al. N. Engl. J. Med. 363, 809–819 (2010).

    Article  CAS  Google Scholar 

  2. Flaherty, K.T. et al. N. Engl. J. Med. 367, 107–114 (2012).

    Article  CAS  Google Scholar 

  3. Solit, D.B. & Rosen, N. N. Engl. J. Med. 364, 772–774 (2011).

    Article  CAS  Google Scholar 

  4. Flaherty, K.T. et al. N. Engl. J. Med. 367, 1694–1703 (2012).

    Article  CAS  Google Scholar 

  5. Ascierto, P.A. et al. Lancet Oncol. 14, 249–256 (2013).

    Article  CAS  Google Scholar 

  6. Jänne, P.A. et al. Lancet Oncol. 14, 38–47 (2013).

    Article  Google Scholar 

  7. Jameson, K.L. et al. Nat. Med. 19, 626–630 (2013).

  8. White, C.D., Erdemir, H.H. & Sacks, D.B. Cell Signal. 24, 826–834 (2012).

    Article  CAS  Google Scholar 

  9. White, C.D., Brown, M.D. & Sacks, D.B. FEBS Lett. 583, 1817–1824 (2009).

    Article  CAS  Google Scholar 

  10. Roy, M., Li, Z. & Sacks, D.B. Mol. Cell Biol. 25, 7940–7952 (2005).

    Article  CAS  Google Scholar 

  11. Zhang, J. et al. Nature 463, 501–506 (2010).

    Article  CAS  Google Scholar 

  12. Brown, M.D. & Sacks, D.B. Cell Signal. 21, 462–469 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Darrin D. Stuart is at the Novartis Institute for Biomedical Research, Emeryville, California, USA.,

    Darrin D Stuart

  2. William R. Sellers is at the Novartis Institute for Biomedical Research, Cambridge, Massachusetts, USA.,

    William R Sellers

Authors
  1. Darrin D Stuart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William R Sellers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Darrin D Stuart.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stuart, D., Sellers, W. Targeting RAF-MEK-ERK kinase-scaffold interactions in cancer. Nat Med 19, 538–540 (2013). https://doi.org/10.1038/nm.3195

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3195

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation